375 related articles for article (PubMed ID: 33264681)
61. [AL amyloidosis, from diagnosis to treatment].
Villesuzanne C; Jaccard A; Nicol M
Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
[TBL] [Abstract][Full Text] [Related]
62. Recent advances in the noninvasive strategies of cardiac amyloidosis.
Zhao L; Fang Q
Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
[TBL] [Abstract][Full Text] [Related]
63. Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.
Nojima Y; Ihara M; Kurimoto T; Nanto S
Am J Case Rep; 2016 Apr; 17():235-40. PubMed ID: 27064109
[TBL] [Abstract][Full Text] [Related]
64. Primary CNS Nonamyloidogenic Light Chain Deposition Disease: Case Report and Brief Review.
Mercado JJ; Markert JM; Meador W; Chapman P; Perry A; Hackney JR
Int J Surg Pathol; 2017 Dec; 25(8):755-760. PubMed ID: 28669250
[TBL] [Abstract][Full Text] [Related]
65. A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing.
Muchtar E; Gertz MA; Kyle RA; Lacy MQ; Dingli D; Leung N; Buadi FK; Hayman SR; Kapoor P; Hwa YL; Fonder A; Hobbs M; Gonsalves W; Kourelis TV; Warsame R; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Rajkumar SV; Kumar SK; Dispenzieri A
Mayo Clin Proc; 2019 Mar; 94(3):472-483. PubMed ID: 30770096
[TBL] [Abstract][Full Text] [Related]
66. Case report: isolated cardiac amyloidosis: an enigma unravelled.
Khalid U; Awar O; Verstovsek G; Cheong B; Yellapragada SV; Jneid H; Deswal A; Virani SS
Methodist Debakey Cardiovasc J; 2015; 11(1):53-8. PubMed ID: 25793032
[TBL] [Abstract][Full Text] [Related]
67. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
[TBL] [Abstract][Full Text] [Related]
68. Light chain deposition disease as a rare cause of restrictive cardiomyopathy.
Koopman P; Van Dorpe J; Maes B; Dujardin K
Acta Cardiol; 2009 Dec; 64(6):821-4. PubMed ID: 20128164
[TBL] [Abstract][Full Text] [Related]
69. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
Fontana M; Ćorović A; Scully P; Moon JC
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
[TBL] [Abstract][Full Text] [Related]
70. Light-chain cardiac amyloidosis.
Mankad AK; Sesay I; Shah KB
Curr Probl Cancer; 2017; 41(2):144-156. PubMed ID: 28117074
[TBL] [Abstract][Full Text] [Related]
71. Rapid deterioration of renal function in a patient with multiple myeloma associated with amyloid and light chain depositions.
Nakayama N; Fujigaki Y; Tsuji T; Sakakima M; Yasuda H; Togawa A; Suzuki H; Fujikura T; Kato A; Baba S; Takahashi S; Hishida A
Clin Exp Nephrol; 2009 Dec; 13(6):671-6. PubMed ID: 19728011
[TBL] [Abstract][Full Text] [Related]
72. Endomyocardial biopsy with co-localization of a lymphoplasmacytic lymphoma and AL amyloidosis.
Leguit RJ; Vink A; de Jonge N; Minnema MC; Oerlemans MIF
Cardiovasc Pathol; 2021; 53():107348. PubMed ID: 34038803
[TBL] [Abstract][Full Text] [Related]
73. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
[TBL] [Abstract][Full Text] [Related]
74. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
75. Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition.
Muchtar E; Dispenzieri A; Lacy MQ; Buadi FK; Kapoor P; Hayman SR; Gonsalves W; Warsame R; Kourelis TV; Chakraborty R; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Rajkumar SV; Dingli D; Leung N; Kyle RA; Kumar SK; Gertz MA
Ann Med; 2017 Nov; 49(7):545-551. PubMed ID: 28271734
[TBL] [Abstract][Full Text] [Related]
76. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
[TBL] [Abstract][Full Text] [Related]
77. Hepatic amyloidosis with light chain deposition disease. A rare association.
Casiraghi MA; De Paoli A; Assi A; Palladini G; Lavazza MT; Beretta A; Gualdoni G; Beretta R
Dig Liver Dis; 2000 Dec; 32(9):795-8. PubMed ID: 11215561
[TBL] [Abstract][Full Text] [Related]
78. Clinical and morphological diagnosis of cardiac AL amyloidosis: a review of findings and difficulties as illustrated in one case.
Prochorec-Sobieszek M; Szufladowicz E; Szaroszyk W; Wagner T; Loukas M
Med Sci Monit; 2005 Aug; 11(8):CS45-8. PubMed ID: 16049384
[TBL] [Abstract][Full Text] [Related]
79. Multiorgan involvement by amyloid light chain amyloidosis.
Li G; Han D; Wei S; Wang H; Chen L
J Int Med Res; 2019 Apr; 47(4):1778-1786. PubMed ID: 30803274
[TBL] [Abstract][Full Text] [Related]
80. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
Tomberli B; Cappelli F; Perfetto F; Olivotto I
JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
